Rankings
▼
Calendar
MCK Q4 2021 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena
MCK
McKesson Corporation
$115B
Q4 2021 Earnings
Healthcare
Medical - Distribution
Income Statement
Revenue
$59.1B
+1.0% YoY
Gross Profit
$3.2B
5.3% margin
Operating Income
$1.1B
1.9% margin
Net Income
$666M
1.1% margin
EPS (Diluted)
$4.15
QoQ Revenue Growth
-5.5%
Cash Flow
Operating Cash Flow
$3.4B
Free Cash Flow
$3.2B
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$65.0B
Total Liabilities
$63.6B
Stockholders' Equity
-$21M
Cash & Equivalents
$6.3B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$59.1B
$58.5B
+1.0%
Gross Profit
$3.2B
$3.1B
+1.8%
Operating Income
$1.1B
$1.2B
-8.3%
Net Income
$666M
$1.0B
-34.8%
Revenue Segments
U.S. Pharmaceutical Segment
$46.6B
69%
International Segment
$17.2B
25%
Medical-Surgical Solutions Segment
$2.7B
4%
Prescription Technology Solutions
$1.4B
2%
← FY 2021
All Quarters
Q1 2022 →